Baxter has notably underperformed the Medical Devices industry over the past year, and analysts are cautious about the ...

Transition amid governance reviews and safety investigations continues Interim finance chief brings background and public ...

In recent days, Baxter International has faced renewed legal scrutiny as law firms announced investigations into alleged governance failures, product safety misstatements around its Novum LVP infusion ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Joel Grade to depart as Baxter CFO; Anita Zielinski named interim CFODEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International ...

Baxter International (NYSE:BAX) is restructuring its business, including a spin-off of its kidney care unit. The company is realigning its portfolio to concentrate on higher margin medical products.

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsKevin Moran - Vice ...

On the unplugged day here at Citi headquarters. And very, very pleased that the next presentation is with Joel Grade, the name from Baxter in case you missed that. And Joel, thank you for being here ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Baxter (NYSE:BAX) and the best and worst ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4, ...

Closure of the Strait of Hormuz could strangle the flow of materials and minerals needed to make ...